Rocket Pharmaceuticals Inc
Research Rocket Pharmaceuticals Inc (RCKT) on Bullrun: market cap USD 271.66M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRCKT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 271.66M
- Financial periodQ2 2026
- RevenueUSD 0
- Net incomeUSD 123.21M
- Free cash flow-USD 39.62M
Valuation Snapshot
latest market cap is USD 271.66M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 223.12M | -USD 190.45M | n/a | -2.01 | USD 77.56M | USD 24.88M | USD 277.22M |
| FY2024 | USD 0 | -USD 258.75M | -USD 215.59M | n/a | -2.73 | USD 163.64M | USD 25.50M | USD 463.23M |
| FY2023 | USD 0 | -USD 245.60M | -USD 211.35M | n/a | -2.92 | USD 55.90M | USD 25.04M | USD 492.57M |
| FY2022 | USD 0 | -USD 221.86M | -USD 186.50M | n/a | -3.26 | USD 140.52M | USD 22.87M | USD 489.69M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 271.66M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 380.20M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.34B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.70B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.54B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.41B | n/a | n/a | n/a |
About Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Rocket Pharmaceuticals Inc's market cap?
Rocket Pharmaceuticals Inc's market capitalization is USD 271.66M.
What does Rocket Pharmaceuticals Inc do?
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States.